http://bmj.com/cgi/content/abstract/324/7335/450
BMJ 2002;324:450 ( 23 February )
Helen E Harris
Public Health Laboratory Service Communicable
Disease Surveillance Centre, London NW9 5EQ
Correspondence to: H E Harris hharris@phls.nhs.uk
Objective: To determine the clinical course of hepatitis C
virus in the first decade of infection in a group of patients who
acquired their infections on a known date.
Design: Cohort study.
Setting: Clinical centres throughout the United Kingdom.
Participants: 924 transfusion recipients infected with the hepatitis
C virus (HCV) traced during the HCV lookback programme and
475 transfusion recipients who tested negative for antibodies to
HCV (controls).
Main outcome measures: Clinical evidence of liver disease and survival
after 10 years of infection.
Results: All cause mortality was not significantly different
between patients and controls (Cox's hazards ratio 1.41, 95%
confidence interval 0.95 to 2.08). Patients were more likely to
be certified with a death related to liver disease than were controls
(12.84, 1.73 to 95.44), but although the risk of death directly
from liver disease was higher in patients than controls this
difference was not significant (5.78, 0.72 to 46.70). Forty per
cent of the patients who died directly from liver disease were known
to have consumed excess alcohol. Clinical follow up of
826 patients showed that liver function was abnormal in 307 (37.2%),
and 115 (13.9%) reported physical signs or symptoms of liver
disease. Factors associated with developing liver disease were
testing positive for HCV ribonucleic acid (odds ratio 6.44, 2.67 to
15.48), having acquired infection when older (at age
40 years;
1.80, 1.14 to 2.85), and years since transfusion (odds ratio
1.096 per year, 1.00 to 1.20). For patients with severe disease,
sex was also significant (odds ratio for women 0.38, 0.17 to
0.88). Of the 362 patients who had undergone liver biopsy, 328 (91%)
had abnormal histological results and 35 (10%) of these were
cirrhotic.
Conclusions: Hepatitis C virus infection did not have a great
impact on all cause mortality in the first decade of infection. Infected
patients were at increased risk of dying directly from liver
disease, particularly if they consumed excess alcohol, but this
difference was not statistically significant.
|
What is already known on this topic Studies that follow patients from disease onset are rare because most HCV
infections are asymptomatic What this study adds Infected patients have an increased risk of dying from a liver related
cause, particularly if they consumed excess alcohol |
ALL
INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR
GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE
KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED
AS PROVIDING MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER OR NOT TO
VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU
ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.